Drug dosing in patients with impaired renal function

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 5, 2009, Pages 483-489

  Brater, D C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

DIALYSIS; DRUG BIOAVAILABILITY; DRUG DISPOSITION; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INFUSION; HUMAN; HYPOALBUMINEMIA; KIDNEY CLEARANCE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KIDNEY FUNCTION TESTS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; RENAL DIALYSIS; RENAL INSUFFICIENCY;

EID: 70350222369     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.135     Document Type: Review

References (28)

1. UpToDate, Waltham, MA, 2007.
2. Brater, D.C. & Hall, S.D. Disposition and dose requirements of drugs in renal insufciency. In Seldin and Giebisch's The Kidney: Physiology and Pathophysiology 4th edn. (eds. Alpern, R.J. & Hebert, S.C.) 2763-2791 (Academic Press, Elsevier, Boston, MA, 2008).
3. Brater, D.C. Drug dosing in renal failure. In Therapy in Nephrology and Hypertension 3rd edn. (ed. Wilcox, C.S.) 1049-1072 (Saunders, Philadelphia, PA, 2008).
4. Drayer, D.E. Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure. Clin. Pharmacokinet. 1, 426-443 (1976).
5. Verbeeck, R.K., Branch, R.A. & Wilkinson, G.R. Drug metabolites in renal failure: pharmacokinetic and clinical implications. Clin. Pharmacokinet. 6, 329-345 (1981).
6. Kunin, C.M. & Finland, M. Restrictions imposed on antibiotic therapy by renal failure. Arch. Intern. Med. 104, 1030-1050 (1959).
7. Cutler, R.E. & Orme, B.M. Correlation of serum creatinine concentration and kanamycin half-life. Therapeutic implications. JAMA 209, 539-542 (1969).
8. Cutler, R.E., Forrey, A.W., Christopher, T.G. & Kimpel, B.M. Pharmacokinetics of furosemide in normal subjects and functionally anephric patients. Clin. Pharmacol. Ther. 15, 588-596 (1974).
9. Dettli, L. Multiple dose elimination kinetics and drug accumulation in patients with normal and with impaired kidney function. Adv. Biosci. 5, 39-54 (1969).
10. Dettli, L. Individualization of drug dosage in patients with renal disease. Med. Clin. North Am. 58, 977-985 (1974).
11. Dettli, L. Drug dosage in renal disease. Clin. Pharmacokinet. 1, 126-134 (1976).
12. Chennavasin, P. & Brater, D.C. Nomograms for drug use in renal disease. Clin. Pharmacokinet. 6, 193-214 (1981).
13. Sarubbi, F.A. & Hull, J.H. Amikacin serum concentrations: prediction of levels and dosage guidelines. Ann. Intern. Med. 89, 612-618 (1978).
14. Atkinson, A.J. Jr. & Umans, J.G. Pharmacokinetic studies in hemodialysis patients. Clin. Pharmacol. Ther., this issue.
15. Grubb, N.G., Rudy, D.W., Brater, D.C. & Hall, S.D. Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a "futile cycle" of elimination. Br. J. Clin. Pharmacol. 48, 494-500 (1999).
16. Holford, N.H.G. & Sheiner, L.B. Kinetics of pharmacologic response. Pharm. Ther. 16, 143-166 (1982).
17. Gibaldi, M. & Levy, G. Pharmacokinetics in clinical practice. I. Concepts. JAMA 235, 1864-1867 (1976).
18. Gibaldi, M. & Levy, G. Pharmacokinetics in clinical practice. 2. Applications. JAMA 235, 1987-1992 (1976).
19. Oie, S. Drug distribution and binding. J. Clin. Pharmacol. 26, 583-586 (1986).
20. Reidenberg, M.M. & Drayer, D.E. Alteration of drug-protein binding in renal disease. Clin. Pharmacokinet. 9 (suppl. 1),18-26 (1984).
21. Benet, L.Z. & Hoener, B.A. Changes in plasma protein binding have little clinical relevance. Clin. Pharmacol. Ther. 71, 115-121 (2002).
22. Greenblatt, D.J., Sellers, E.M. & Koch-Weser, J. Importance of protein binding for the interpretation of serum or plasma drug concentrations. J. Clin. Pharmacol. 22, 259-263 (1982).
23. Sheiner, L.B., Rosenberg, B. & Marathe, V.V. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J. Pharmacokinet. Biopharm. 5, 445-479 (1977).
24. Gault, M.H., Churchill, D.N. & Kalra, J. Loading dose of digoxin in renal failure. Br. J. Clin. Pharmacol. 9, 593-597 (1980).
25. Gibson, T.B. & Nelson, H.A. Drug kinetics and artifcial kidneys. Clin. Pharmacokinet. 2, 403-426 (1977).
26. Keller, E., Reetze, P. & Schollmeyer, P. Drug therapy in patients undergoing continuous ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations. Clin. Pharmacokinet. 18, 104-117 (1990).
27. Reetze-Bonorden, P., Böhler, J. & Keller, E. Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations. Clin. Pharmacokinet. 24, 362-379 (1993).
28. Bressolle, F., Kinowski, J.M., de la Coussaye, J.E., Wynn, N., Eledjam, J.J. & Galtier, M. Clinical pharmacokinetics during continuous haemofltration. Clin. Pharmacokinet. 26, 457-471 (1994).